🔴 Solid Biosciences is trading 5.3% down today in pre-market with no clear company-specific catalyst identified

Solid Biosciences is trading 5.29% down at $8.60 in the August 14, 2026 pre-market, with no clear company-specific catalyst identified.

• Its latest notable developments were the August 6 second-quarter update and potential $200 million stock offering, both predating the move.
• Broader markets are slightly mixed rather than sharply risk-off, making the drop appear stock-specific but unexplained.
• Closes rose from $8.39 on August 7 to $9.08 on August 13, suggesting possible profit-taking, though unconfirmed.